Life science company MilliporeSigma said Monday it opened its new $65 million, high-potent active pharmaceutical ingredients production facility in Verona, bringing 50 new jobs to the Madison area.

MilliporeSigma, the Burlington, Massachusetts-based U.S. and Canada Life Science business of Merck KGaA in Darmstadt, Germany, said the 70,000-square-foot facility doubles the company’s production of high-potent active pharmaceutical ingredients (HPAPIs), allowing the company to meet a growing need for the key cancer treatment components, said Dirk Lange, head of life science services, Life Science business sector of Merck.

“There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics. Lower-doses of these therapies reduce the negative side effects for patients who are taking on this critical fight,” said Lange in a press release.

Click here to read the full article.